Clinical-epidemiologic Variation in Patients Treated in the First and Second Wave of COVID-19 in Lambayeque, Peru: A Cluster Analysis
Overview
Authors
Affiliations
Objectives: To identify differences in the clinical and epidemiologic characteristics of patients during the first and second waves of the COVID-19 pandemic at the EsSalud Lambayeque health care network, Peru.
Methods: An analytical cross-sectional study of 53,912 patients enrolled during the first and second waves of COVID-19 was conducted. Cluster analysis based on clustering large applications (CLARA) was applied to clinical-epidemiologic data presented at the time of care. The two pandemic waves were compared using clinical-epidemiologic data from epidemiologic surveillance.
Results: Cluster analysis identified four COVID-19 groups with a characteristic pattern. Cluster 1 included the largest number of participants in both waves, and the participants were predominantly female. Cluster 2 included patients with gastrointestinal, respiratory, and systemic symptoms. Cluster 3 was the "severe" cluster, characterized by older adults and patients with dyspnea or comorbidities (cardiovascular, diabetes, obesity). Cluster 4 included asymptomatic, pregnant, and less severe patients. We found differences in all clinical-epidemiologic characteristics according to the cluster to which they belonged.
Conclusion: Using cluster analysis, we identified characteristic patterns in each group. Respiratory, gastrointestinal, dyspnea, anosmia, and ageusia symptoms were higher in the second COVID-19 wave than the first COVID-19 wave.
Mounesan L, Gharibzadeh S, Parsaeian M, Gouya M, Eybpoosh S, Hosseini A Med J Islam Repub Iran. 2024; 38:93.
PMID: 39678761 PMC: 11644032. DOI: 10.47176/mjiri.38.93.
COVID-19 patient profiles over four waves in Barcelona metropolitan area: A clustering approach.
Fernandez D, Perez-Alvarez N, Molist G PLoS One. 2024; 19(5):e0302461.
PMID: 38713649 PMC: 11075871. DOI: 10.1371/journal.pone.0302461.
Valladares-Garrido D, Dominguez-Troncos H, Picon-Reategui C, Valdiviezo-Morales C, Vera-Ponce V, Failoc-Rojas V Front Psychiatry. 2024; 15:1309957.
PMID: 38544848 PMC: 10966908. DOI: 10.3389/fpsyt.2024.1309957.
Valladares-Garrido D, Zila-Velasque J, Santander-Hernandez F, Guevara-Morales M, Morocho-Alburqueque N, Failoc-Rojas V Front Psychiatry. 2024; 14:1287036.
PMID: 38348360 PMC: 10859463. DOI: 10.3389/fpsyt.2023.1287036.
Alvarado-Gamarra G, Zarate-Campos V, Saavedra Diaz J, Sanchez Julca R, Tahua Vega A, Borcic A Rev Peru Med Exp Salud Publica. 2024; 40(2):200-206.
PMID: 38232266 PMC: 10953665. DOI: 10.17843/rpmesp.2023.402.12409.